Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

310 To Left

How Tim Wakefield Inspired Garrett Whitlock’s Dedication to the Jimmy Fund | | 310 To Left

13 Aug 2024

Description

In this emotional and revealing interview, MLB pitcher Garrett Whitlock opens up about how the legendary Tim Wakefield profoundly influenced his commitment to the Jimmy Fund and his drive to support the fight against pediatric cancer. Garrett discusses the deep impact Tim Wakefield’s philanthropic legacy has had on him, especially Wakefield’s long-standing support for the Jimmy Fund and his tireless efforts to make a difference. Whitlock shares how Wakefield’s example of generosity and dedication to the cause inspired him to take a more active role in the Jimmy Fund’s mission. Through personal anecdotes and heartfelt reflections, Garrett reveals how Wakefield’s work has shaped his own approach to charity, especially after becoming a father. He talks about how the values and passion exemplified by Wakefield have motivated him to support the Jimmy Fund with greater urgency and compassion. For the full episode of 310 To Left, click here https://youtube.com/live/F4DaK9CNl7g GET NESN 360: https://nesn.com/download-the-nesn-app/ Subscribe on YouTube: https://www.youtube.com/NESN Twitter: https://twitter.com/NESN Facebook: https://www.facebook.com/NESN/ Instagram: https://www.instagram.com/nesn TikTok: https://www.tiktok.com/@nesn Twitch: https://twitch.tv/nesn/ Subscribe to our channel for more inspirational stories, exclusive interviews, and updates on impactful causes! #GarrettWhitlock #TimWakefield #JimmyFund #PediatricCancer #Inspiration #Charity #Philanthropy #Legacy Learn more about your ad choices. Visit megaphone.fm/adchoices

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.